Clinical Trial Update: Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial update investigating metformin, dapagliflozin, and their combination with pioglitazone in patients with type 2 diabetes and insulin resistance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• PIOGLITAZONE (Pioglitazone)
• metformin (metformin)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Type2diabetes, Insulin Resistance | Phase 3 | Status: UNKNOWN